Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Quick Stats
May 14, 202661.1
AI Score
BUY0.25
Volume Ratio
May 05, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
EXEL Stock Summary
Last updated May 14, 2026
EXEL is currently trading at $50.9, positioned above its 200-day moving average of $41.88, indicating a long-term uptrend. The stock has a 52-week range of $33.755 to $51.63.
Technical Analysis: The 50-day moving average stands at $44.17, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 66.649, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.04, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates EXEL at 61.1/100 with a BUY recommendation.
EXEL (Exelixis Inc) Indicators
Last updated May 14, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 66.649 |
| CMF (20) | 0.04 |
| ROC (10) | 14.485 |
| ADX (14) | 32.731 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.626 |
| AROONOSC (14) | 57.143 |
| WILLAMS %R (14) | -8.979 |
| MFI (14) | 65.981 |
EXEL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
EXEL Price vs Max Options Open Interest
EXEL Max Change In Options Open Interest
EXEL Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EXEL Daily Out of Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EXEL Daily In the Money Options - Sort by Max open Interest (near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
EXEL Most Active Options by Volume(near term)
14th May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Exelixis Inc is above both 50 Day and 200 Day SMA which is considered Bullish.
EXEL Moving Averages Analysis
Exelixis Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on May 14, 2026
Exelixis Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 14, 2026
EXEL (Exelixis Inc) Simple Moving Averages
Moving Averages are last updated May 14, 2026
| Days | MA |
|---|---|
| 10 | 47.67 |
| 20 | 46.38 |
| 30 | 45.76 |
| 50 | 44.17 |
| 100 | 44.03 |
| 200 | 41.88 |
EXEL Fundamental Analysis
| P/E (Forward) | 15.2439 |
| P/E (Trailing) | 16.3775 |
| Market Cap ($) | 12.4 billion |
| Earnings/Share ($) | 3.02 |
| Net Proft Margin (%) | 0.3508 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 3.5691 |
| EPS Estimate Next Year ($) | 4.0482 |
| WallStreet Target Price ($) | 49.0588 |
| Most Recent Quarter |